Publications by authors named "Ivan Zatta"

Claim this Profile
B
Belamaf: Is Renal Toxicity an Overlooked Side Effect?
Gisella Vischini, Paola Tacchetti, Laura Pavan, Simona Barbuto, Daniele Vetrano, Ivan Zatta

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi, Ivan Zatta

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta, Ivan Zatta

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Andrea Visentin, Francesca Romana Mauro, Lydia Scarfò, Massimo Gentile, Lucia Farina, Ivan Zatta

Am J Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Ivan Zatta

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis